Edesa Biotech Inc
EDSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$44.51M
Close$
$1.90
60.1% downside
Current Fair Value
60.1% downsideOvervalued by 60.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $44.51 Million |
|---|---|
| Enterprise Value | $34.17 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.27 |
| Beta | 1.08 |
| Outstanding Shares | 9,007,000 |
Return
| Return on Equity | -110.85% |
|---|---|
| Return on Assets | -110.85% |
| Return on Invested Capital | -162.31% |
Valuation & Multiples
| P/E Ratio | -2.73 |
|---|---|
| PEG | -1.31 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 671.14 |
| Enterprise Value to EBIT | -2.39 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 11, 2026
EPS Estimate
$-0.58
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 30.95%▼ 7.34% |
|---|---|
| Total Invested | $13.83M▲ 218.65% |
| Investors Holding | 27▲ 6.00% |
ESG Score
No data